Skip to content

   Pharma Publications

Neuropsychopharmacology
  • The might of light for revealing neuropsychiatric mechanisms
    Published on 2024-09-12
    2 years ago
  • Leveraging ultra-high field (7T) MRI in psychiatric research
    Published on 2024-09-09
    2 years ago
  • Correction: Identifying dysfunctional cell types and circuits in animal models for psychiatric disorders with calcium imaging
    Published on 2024-09-09
    2 years ago
  • Revisiting the role of computational neuroimaging in the era of integrative neuroscience
    Published on 2024-09-06
    2 years ago
  • Multi-level therapeutic actions of cannabidiol in ketamine-induced schizophrenia psychopathology in male rats
    Published on 2024-09-06
    2 years ago
  • Astrocytic RARγ mediates hippocampal astrocytosis and neurogenesis deficits in chronic retinoic acid-induced depression
    Published on 2024-09-06
    2 years ago
  • Reporting checklists in neuroimaging: promoting transparency, replicability, and reproducibility
    Published on 2024-09-06
    2 years ago
« Previous 1 … 74 75 76 77 78 … 143 Next »
Journal of Psychopharmacology
  • Commentary on Cochrane review: “Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder”
    Published on 2022-10-11
    4 years ago
  • Pharmaco-fUS in cognitive impairment: Lessons from a preclinical model
    Published on 2022-10-07
    4 years ago
  • Associations between MDMA/ecstasy use and physical health in a U.S. population-based survey sample
    Published on 2022-10-03
    4 years ago
  • The low risk for early renal damage during lithium treatment has not changed over time
    Published on 2022-09-19
    4 years ago
  • Individual differences in cocaine-induced conditioned place preference in male rats: Behavioral and transcriptomic evidence
    Published on 2022-09-19
    4 years ago
  • The association between N-methyl-d-aspartate receptor availability and glutamate levels: A multi-modal PET-MR brain imaging study in first-episode psychosis and healthy controls
    Published on 2022-09-19
    4 years ago
  • Deepening our understanding of psychedelics by expanding psychedelic data collection in the United States National Survey on Drug Use and Health
    Published on 2022-09-16
    4 years ago
« Previous 1 … 74 75 76 77 78 … 150 Next »
European Neuropsychopharmacology
  • Effectiveness of Fluvoxamine at preventing COVID-19 infection from turning severe
    Published on 2022-12-13
    4 years ago
  • Brain correlates of subjective cognitive complaints in COVID-19 survivors: a multimodal magnetic resonance imaging study
    Published on 2022-12-12
    4 years ago
  • Disrupting the nNOS/NOS1AP interaction in the medial prefrontal cortex impairs social recognition and spatial working memory in mice
    Published on 2022-12-11
    4 years ago
  • Is there such a thing as gambling dual disorder? Preliminary evidence and clinical profiles
    Published on 2022-12-11
    4 years ago
  • Relapse, cognitive reserve, and their relationship with cognition in first episode schizophrenia: a 3-year follow-up study
    Published on 2022-12-08
    4 years ago
  • Effects of ketamine optical isomers, fluoxetine and naloxone on timing in differential reinforcement of low-rate response (DRL) 72-s task in rats
    Published on 2022-12-06
    4 years ago
  • Effects of quetiapine on sleep: A systematic review and meta-analysis of clinical trials
    Published on 2022-12-02
    4 years ago
« Previous 1 … 74 75 76 77 78 … 168 Next »

   Pharma Pub